Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
October 20 2020 - 3:43PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF
1934
For the month of October 2020
Commission File Number: 001-39034
BELLUS HEALTH INC.
(Name of registrant)
275 Armand-Frappier Blvd.
Laval, Québec
H7V 4A7
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
¨
Form 20-F x
Form 40-F
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
BELLUS Health Inc.
|
|
|
|
|
|
|
|
|
Date: October 20, 2020
|
By:
|
/s/ François Desjardins
|
|
|
|
Name: François Desjardins
Title: Vice President, Finance
|
|
Form 6-K Exhibit Index
Exhibit 99.1 of this report on Form 6-K is incorporated by reference
into the Company’s registration statement on Form F-10 (File No. 333-235637).
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Apr 2024 to May 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From May 2023 to May 2024